Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21988 | 341 | 35.5 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PLASMA VEGF | Author keyword | 3 | 57% | 1% | 4 |
| 2 | MANCHESTER RENAL GRP | Address | 2 | 67% | 1% | 2 |
| 3 | PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR | Author keyword | 2 | 67% | 1% | 2 |
| 4 | SERUM VEGF | Author keyword | 2 | 36% | 1% | 4 |
| 5 | CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR | Author keyword | 1 | 100% | 1% | 2 |
| 6 | VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS | Author keyword | 1 | 100% | 1% | 2 |
| 7 | ANGIOGENETIC FACTOR | Author keyword | 1 | 50% | 0% | 1 |
| 8 | BIOLOGICAL TUMOUR MARKER | Author keyword | 1 | 50% | 0% | 1 |
| 9 | C FORLANINI HOSP | Address | 1 | 50% | 0% | 1 |
| 10 | CANINE NON HODGKIN LYMPHOMA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PLASMA THROMBOSPONDIN LEVELS | 4 | 75% | 1% | 3 |
| 2 | ANGIOGENIC CYTOKINE | 3 | 50% | 1% | 5 |
| 3 | SERUM VEGF | 3 | 39% | 2% | 7 |
| 4 | CIRCULATING VEGF LEVELS | 3 | 60% | 1% | 3 |
| 5 | EPITHELIAL OVARIAN NEOPLASMS | 3 | 60% | 1% | 3 |
| 6 | CONTAIN HIGH LEVELS | 2 | 67% | 1% | 2 |
| 7 | FACTOR C LEVEL | 1 | 50% | 1% | 2 |
| 8 | TUMOR TISSUE CONTENT | 1 | 50% | 0% | 1 |
| 9 | VEGF RII INFLUENCES | 1 | 50% | 0% | 1 |
| 10 | PRIMARY COLORECTAL CARCINOMA | 1 | 25% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer | 2007 | 91 | 94 | 36% |
| A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful? | 2002 | 77 | 56 | 46% |
| Clinical implications of circulating angiogenic factors in cancer patients | 2001 | 357 | 183 | 21% |
| Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood | 2006 | 187 | 155 | 12% |
| Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? | 2004 | 19 | 30 | 50% |
| Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer | 2012 | 16 | 108 | 15% |
| Glycosaminoglycan-binding cytokines as tumor markers | 2008 | 19 | 143 | 22% |
| Pitfalls in the measurement of circulating vascular endothelial growth factor | 2001 | 195 | 59 | 17% |
| An integrative model for vascular endothelial growth factor A as a tumour biomarker | 2010 | 6 | 61 | 21% |
| Anti-VEGF therapy: the search for clinical biomarkers | 2008 | 22 | 55 | 11% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MANCHESTER RENAL GRP | 2 | 67% | 0.6% | 2 |
| 2 | C FORLANINI HOSP | 1 | 50% | 0.3% | 1 |
| 3 | CSF PHYSIOL NEUROL | 1 | 50% | 0.3% | 1 |
| 4 | HAEMOSTASIS THROMBOSIS VASC BIOL | 1 | 50% | 0.3% | 1 |
| 5 | MF VLADIMIRSKII MOSCOW REG CLIN | 1 | 50% | 0.3% | 1 |
| 6 | MULTIDISCIPLINARY INTER BIOBANK BIOBIM | 1 | 50% | 0.3% | 1 |
| 7 | OBST GYNAECOL | 1 | 50% | 0.3% | 1 |
| 8 | SERV CIRURG GEN ARATO DIGEST | 1 | 50% | 0.3% | 1 |
| 9 | VET MORPHOPHISIOL ANIM PROD | 1 | 50% | 0.3% | 1 |
| 10 | TUMOR MARKERS | 0 | 14% | 0.9% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000278831 | MICROVESSEL DENSITY//MICROVESSEL COUNT//CHALKLEY |
| 2 | 0.0000235797 | ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL |
| 3 | 0.0000233992 | FLT 1//VEGF RECEPTORS//VEGF165B |
| 4 | 0.0000219485 | TSU 68//APATINIB//MUCOCUTANEOUS TOXICITIES |
| 5 | 0.0000203513 | PEROPERATIVE BLEEDING//PRIMARY PROSTATE CULTURE//BLOOD VESSEL MORPHOLOGY |
| 6 | 0.0000170600 | VEGF POLYMORPHISMS//VEGF POLYMORPHISM//RS2010963 |
| 7 | 0.0000156359 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |
| 8 | 0.0000135858 | OREGOVOMAB//AFLIBERCEPT//GI PERFORATION |
| 9 | 0.0000103070 | FERTILITY CYCLE//CHRONOEPIDEMIOLOGY//SCREENING CAMPAIGNS |
| 10 | 0.0000079419 | ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII |